Skip to content
Subcommittee on Crime and Terrorism

Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion, and Fraud

Type: Full Committee Hearing
Date:
Time: 09:00am
Location: Dirksen-226

Member Statements

Panel I

  • Sherrod Brown

    United States Senator
    State of Ohio

Panel II

  • R. Gil Kerlikowske

    Director
    White House Office of National Drug Control Policy
    Washington, DC
  • Michele M. Leonhart

    Administrator
    United States Drug Enforcement Administration
    Washington, DC

Panel III

  • Laura Hosley

    Manager, Community Prevention
    Rhode Island Student Assistance Services
    Warwick, RI
  • John Eadie

    Director, Prescription Monitoring Program Center of Excellence
    Brandeis University
    Waltham, MA